In a study to explore the effects of atorvastatin therapy on hormonal and metabolic parameters in women with PCOS, lipid profile and inflammatory markers showed improvement, but insulin sensitivity worsened during six months of atorvastatin therapy (20mg) [41]. This evidence concerns the gene INS and polycystic ovary syndrome.